“We have an overwhelming therapeutic toolbox to eliminate death and suffering from Covid. For U.S., the end of the pandemic is now in clear view, and secure. We need to evenly distribute this triumph of science over disease around the world, and make sure this never happens again.”
France is seeing an increase in cases, and in COVID-19 hospitalisations, even if, thanks to one of Europe’s highest vaccination rates, there has been less impact on hospital numbers than in previous waves of the pandemic.
Nov 5 (Reuters) – A trial of Pfizer Inc’s experimental antiviral pill for situs judi slot paling gacor COVID-19 was shown to cut by 89% the chances of hospitalization or death for adults at risk of developing severe disease, a “stunning” result that potentially adds another weapon to combat the pandemic.
A 46-year-old man was arrested at Fairfield Police Station about 10pm on Friday, and charged with attempt murder, causing grievous bodily harm to person with intent and assault occasioning actual bodily harm.
“This is even bigger than the Merck drug.” “This one knocked it out of the park – 89% versus 50%. But also, they had different endpoints, 8% in the placebo group for the Pfizer, 14% in Merck … This is huge, because now we’re going to have two drugs.”
“The oral treatments will be an important option for patients who are either unvaccinated or vaccinated and looking to reduce their risk of severe illness, especially if they are at high risk for severe illness.” (Reporting by Ankur Banerjee and Leroy Leo in Bengaluru and Julie Steenhuysen in Chicago; Editing by Anil D’Silva and Arun Koyyur)
‘The corporations and business leaders who picked up awards are dynamic and reflect the huge efforts corporate organisations are now making to improve diversity and inclusion. We should never forget how far we’ve come but there is still so much more to do,’ she added.
‘I was honoured to present the Lifetime Achievement award to Professor Frank Joseph, who has overseen the rollout of COVID-19 testing in private clinics across the UK and Europe and has been at the forefront of the fight against the pandemic with the NHS and Dam Health,’ she added.
“If authorized by the FDA we may soon have pills that treat the virus in those who become infected. We’ve already secured millions of doses. The therapy would be another tool in our toolbox to protect people from the worst outcomes of COVID.”
The Awards, which were created in 2010, reward 16 categories including: Diversity in Tech, Campaigner, Charity, Community Project, Company, Diversity Champion, Diversity Team, Head of Diversity, Hero, Inspirational Role Model.
And the national charity, The Oliver King Foundation, was named Charity of the Year for its efforts to install defibrillators in schools around the country and lobbied the government to pass a law making the equipment mandatory for every institution.
Professor Joseph, a world-leading physician in Endocrinology and Diabetes at the Countess of Chester Hospital, received the award for his work fighting coronavirus for the NHS and private medical and diagnostics company Dam Health.
The awards champion diversity and inclusion by recognising achievements across race, sexual orientation, gender identity, disability and religion. Linda Riley, European Diversity Awards founder, said: ‘These awards shine a light on those who have worked tirelessly to champion diversity and inclusion during what has been an extremely difficult 18 months with Covid-19.